| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.0093 | 1 |
| mRNA | navitoclax:piperlongumine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.001 | 1 |
| mRNA | PD-0332991 | FIMM | pan-cancer | AAC | -0.0039 | 1 |
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | 0.0008 | 1 |
| mRNA | JNK-9L | GDSC1000 | pan-cancer | AAC | 0.00069 | 1 |
| mRNA | BRD-K26531177 | CTRPv2 | pan-cancer | AAC | 0.0006 | 1 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | -0.00051 | 1 |
| mRNA | VX-680 | GDSC1000 | pan-cancer | AAC | -0.00079 | 1 |
| mRNA | temsirolimus | FIMM | pan-cancer | AAC | 0.0021 | 1 |